Alveolar epithelial paxillin in postnatal lung alveolar development

Area of Science:

• Cell Biology
• Developmental Biology
• Pulmonology

Background:

• Paxillin is a focal adhesion protein vital for embryonic development, controlling cell motility and angiogenesis.
• Its specific role in lung development, particularly in alveolar epithelial cells, is not well understood.

Purpose of the Study:

• To investigate the function of paxillin in mouse lung development.
• To elucidate the molecular mechanisms by which paxillin influences alveolar development and surfactant homeostasis.

Main Methods:

• Utilized tamoxifen-inducible PxniΔAT2 neonatal mice for conditional knockdown of paxillin in alveolar epithelial type 2 (AT2) cells.
• Assessed lung structure, compliance, survival rates, surfactant protein expression, lamellar body formation, and the expression of CEBPA and ABCA3.

Main Results:

• Paxillin expression is upregulated in AT2 cells during the alveolar stage (postnatal day 10) compared to the saccular stage (postnatal day 0).
• PxniΔAT2 mice exhibited disrupted alveolar and vascular structures, reduced lung compliance, and lower survival rates.
• Surfactant protein expression, lamellar body structure, and the CEBPA-ABCA3 signaling pathway were inhibited in PxniΔAT2 neonatal mouse lungs.

Conclusions:

• Paxillin plays a critical role in postnatal lung alveolar development.
• Paxillin regulates lung development in AT2 cells through the CEBPA-ABCA3 signaling pathway.
• Targeting paxillin in AT2 cells may offer novel therapeutic strategies for neonatal lung developmental disorders.